Yu.O. Nikolaeva
Yu.O. Nikolaeva has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Yu. Ovchinnikov
Russian University of Medicine, Moscow, 127473, Russian Federation
13 shared publications - Nina A. Miroshnichenko
Russian University of Medicine
13 shared publications - M.M. Vasilyev
G.V. Kurdyumov Institute for Metal Physics
2 shared publications - N. P. Jimsheleishvili
Yevdokimov Moscow State University of Medicine and Dentistry
2 shared publications - V. A. Ryabinin
Yevdokimov Moscow State University of Medicine and Dentistry
2 shared publications - V. A. Simsova
Yevdokimov Moscow State University of Medicine and Dentistry
2 shared publications
Latest Publications
- 12 May 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (2) , 38-42
Clinical and morphological substantiation of the effectiveness of topical antimicrobial therapy for acute tonsillopharyngitis
Since the COVID-19 pandemic, there has been an increase in the inappropriate use of systemic antibiotics for acute upper respiratory tract infections. In 75% of cases, doctors prescribe antibiotics despite the fact that 80% of such diseases have a viral etiology. The main causes are the following: challenges in differential diagnosis of the causative agent, ignoring clinical guidelines and pressure from patients. Consequences: growth of antibiotic resistance, increased incidence of chronic diseases, side effects, high healthcare costs. Objective. To determine the effectiveness of Dorithricin combination drug in patients with acute non-streptococcal tonsillopharyngitis using cytomorphometry. Material and methods. A study for evaluating the effectiveness of Dorithricin combination drug, which contains tyrothricin and has a two-stage mechanism of action that prevents the development of resistance, in patients with acute non-streptococcal tonsillopharyngitis using cytomorphometry was carried out at the department of otorhinolaryngology of the Russian University of Medicine. The study included 30 patients with acute tonsillopharyngitis of non-streptococcal etiology, aged 22—62 years, with a disease duration of 1 to 3 days at the time of inclusion and a negative rapid strep test result. Using subjective and objective research methods, data indicating the high effectiveness of Dorithricin combination drug (in the treatment of inflammatory diseases of the oropharynx) were obtained. Conclusion. The use of Dorithricin drug in the treatment of acute tonsillopharyngitis not only allows to rapidly relieve inflammation but also restores the overall well-being of patients without the risk of developing antibiotic resistance.
- 12 May 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (2) , 38-42
Clinical and morphological substantiation of the effectiveness of topical antimicrobial therapy for acute tonsillopharyngitis
Since the COVID-19 pandemic, there has been an increase in the inappropriate use of systemic antibiotics for acute upper respiratory tract infections. In 75% of cases, doctors prescribe antibiotics despite the fact that 80% of such diseases have a viral etiology. The main causes are the following: challenges in differential diagnosis of the causative agent, ignoring clinical guidelines and pressure from patients. Consequences: growth of antibiotic resistance, increased incidence of chronic diseases, side effects, high healthcare costs. Objective. To determine the effectiveness of Dorithricin combination drug in patients with acute non-streptococcal tonsillopharyngitis using cytomorphometry. Material and methods. A study for evaluating the effectiveness of Dorithricin combination drug, which contains tyrothricin and has a two-stage mechanism of action that prevents the development of resistance, in patients with acute non-streptococcal tonsillopharyngitis using cytomorphometry was carried out at the department of otorhinolaryngology of the Russian University of Medicine. The study included 30 patients with acute tonsillopharyngitis of non-streptococcal etiology, aged 22—62 years, with a disease duration of 1 to 3 days at the time of inclusion and a negative rapid strep test result. Using subjective and objective research methods, data indicating the high effectiveness of Dorithricin combination drug (in the treatment of inflammatory diseases of the oropharynx) were obtained. Conclusion. The use of Dorithricin drug in the treatment of acute tonsillopharyngitis not only allows to rapidly relieve inflammation but also restores the overall well-being of patients without the risk of developing antibiotic resistance.
- 27 March 2026
- Published by Media Sphere Publishing Group in Russian Rhinology
- Vol. 34 (1) , 19-26
Classification of maxillary sinus states according to digital diaphanoscopy with the use of machine learning
Currently, the issue of diagnosis of pathological changes in the maxillary sinus (MS) is an urgent task. The digital diaphanoscopy method, which allows to visualize the tissues of sinuses through the use of probing optical radiation in red and near-infrared ranges, seems promising for the early diagnosis of this pathology. However, there is a need to improve the accuracy of this method, reduce the time of study and simplify the process of recorded images (diaphanograms) classification by creating a medical decision making support system (MDMSS). Objective. To develop a MDMSS for classification of diaphanograms of digital diaphanoscopy on the basis of a convolutional neural network (CNN). Patients and methods. The study involved 80 healthy volunteers and 76 patients with MS pathology. Diaphanograms were recorded using a digital diaphanoscopy device at two probing wavelengths (650 and 850 nm). Analysis of diaphanograms (160 diaphanograms of conditionally healthy volunteers, 78 diaphanograms of patients with sinusitis and 32 diphanograms of patients with MS cyst) was carried out using a developed image classification model based on ResNet-50 CNN. Results. High accuracy values (sensitivity of 0.95 and specificity of 0.88), which exceeded all previously proposed developments based on linear discriminant analysis, were obtained. The problem of MS pathology differentiation into sinusitis and cystic fluid classes was solved by means of developed MDMSS. Conclusion. The developed classification model can be applied for digital diaphanoscopy for the purpose of early detection of MS pathological changes in telemedicine and automated ENT consultations using MDMSS. Analysis of the results showed the need to expand the database for further training of the classification model.
- 27 March 2026
- Published by Media Sphere Publishing Group in Russian Rhinology
- Vol. 34 (1) , 19-26
Classification of maxillary sinus states according to digital diaphanoscopy with the use of machine learning
Currently, the issue of diagnosis of pathological changes in the maxillary sinus (MS) is an urgent task. The digital diaphanoscopy method, which allows to visualize the tissues of sinuses through the use of probing optical radiation in red and near-infrared ranges, seems promising for the early diagnosis of this pathology. However, there is a need to improve the accuracy of this method, reduce the time of study and simplify the process of recorded images (diaphanograms) classification by creating a medical decision making support system (MDMSS). Objective. To develop a MDMSS for classification of diaphanograms of digital diaphanoscopy on the basis of a convolutional neural network (CNN). Patients and methods. The study involved 80 healthy volunteers and 76 patients with MS pathology. Diaphanograms were recorded using a digital diaphanoscopy device at two probing wavelengths (650 and 850 nm). Analysis of diaphanograms (160 diaphanograms of conditionally healthy volunteers, 78 diaphanograms of patients with sinusitis and 32 diphanograms of patients with MS cyst) was carried out using a developed image classification model based on ResNet-50 CNN. Results. High accuracy values (sensitivity of 0.95 and specificity of 0.88), which exceeded all previously proposed developments based on linear discriminant analysis, were obtained. The problem of MS pathology differentiation into sinusitis and cystic fluid classes was solved by means of developed MDMSS. Conclusion. The developed classification model can be applied for digital diaphanoscopy for the purpose of early detection of MS pathological changes in telemedicine and automated ENT consultations using MDMSS. Analysis of the results showed the need to expand the database for further training of the classification model.
- Open Access
- 13 October 2024
- Published by Consilium Medicum in Consilium Medicum
- Vol. 26 (9) , 575-578
Acute respiratory viral infections: Consensus on rational therapy
There are diseases for which people turn to specific specialists, but there are also a number of ones that are treated by doctors of different specialties. Therapists, infectious disease specialists, otolaryngologists, and pulmonologists diagnose and treat acute respiratory viral infections. But the same specialists often have to deal with the outcomes of an acute process – postnasal drip and post-infectious cough, which decreases the quality of life and exhaust patients. However, in case when the correct diagnosis is made, there are treatment regimens that allow to achieve quick relieve subjective and objective symptoms, as well as clinical cure of the disease escaping the use of antibacterial therapy. The efficient therapy agreement of the otolaryngologist and pulmonologist is that for various causes of cough, herbal medicine is the best choice.
- 13 October 2024
- Published by Consilium Medicum in Consilium Medicum
- Vol. 26 (9) , 575-578
Open AccessAcute respiratory viral infections: Consensus on rational therapy
There are diseases for which people turn to specific specialists, but there are also a number of ones that are treated by doctors of different specialties. Therapists, infectious disease specialists, otolaryngologists, and pulmonologists diagnose and treat acute respiratory viral infections. But the same specialists often have to deal with the outcomes of an acute process – postnasal drip and post-infectious cough, which decreases the quality of life and exhaust patients. However, in case when the correct diagnosis is made, there are treatment regimens that allow to achieve quick relieve subjective and objective symptoms, as well as clinical cure of the disease escaping the use of antibacterial therapy. The efficient therapy agreement of the otolaryngologist and pulmonologist is that for various causes of cough, herbal medicine is the best choice.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 89 (4) , 14-19
About new possibilities for optimizing the postoperative period in tonsillectomy
Tonsillectomy is one of the most frequent surgical interventions in otorhinolaryngology. This surgical is always accompanied by the development of reactive inflammatory phenomena and pain syndrome. The effectiveness and safety of tonsillectomy can be improved through the use of topical treatment in the postoperative period, including antiseptics in the form of a spray. An observational study was conducted at the Department of Otorhinolaryngology of the Russian University of Medicine of the Ministry of Health of the Russian Federation, the purpose of which was to evaluate the clinical efficacy, tolerability and safety of Viroxynol for oral and throat mucosa in patients after tonsillectomy. As a result of the analysis of the data obtained, it was found that the use of Viroxynol for the mucous membrane of the oral cavity and throat in the treatment of patients in the early postoperative period causes a pronounced clinical effect, reduces the need for additional medications, allows faster reduction of pain syndrome against the background of relief of reactive inflammatory phenomena, improves the quality of life of patients, accelerates the healing process, reduces the risk of bacterial inflammation. The drug may be recommended for use in patients after tonsillectomy.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 89 (4) , 14-19
About new possibilities for optimizing the postoperative period in tonsillectomy
Tonsillectomy is one of the most frequent surgical interventions in otorhinolaryngology. This surgical is always accompanied by the development of reactive inflammatory phenomena and pain syndrome. The effectiveness and safety of tonsillectomy can be improved through the use of topical treatment in the postoperative period, including antiseptics in the form of a spray. An observational study was conducted at the Department of Otorhinolaryngology of the Russian University of Medicine of the Ministry of Health of the Russian Federation, the purpose of which was to evaluate the clinical efficacy, tolerability and safety of Viroxynol for oral and throat mucosa in patients after tonsillectomy. As a result of the analysis of the data obtained, it was found that the use of Viroxynol for the mucous membrane of the oral cavity and throat in the treatment of patients in the early postoperative period causes a pronounced clinical effect, reduces the need for additional medications, allows faster reduction of pain syndrome against the background of relief of reactive inflammatory phenomena, improves the quality of life of patients, accelerates the healing process, reduces the risk of bacterial inflammation. The drug may be recommended for use in patients after tonsillectomy.
- Open Access
- 8 April 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 52-63
Recommendations for topical antimicrobial therapy of inflammatory diseases of the middle ear based on the results of evidence-based clinical study
Introduction. In conditions of widespread resistance of pathogens to traditional antimicrobial drugs, active attention is paid to the development of topical antimicrobial drugs for the effective treatment of inflammatory pathology of the middle ear.Aim. To study the efficacy and safety of a new dosage form of the drug Dioxydin® (2.5 mg/ml ear drops) in the treatment of patients with acute purulent otitis media and exacerbation of chronic purulent otitis media in comparison with ear drops containing 0.3% ciprofloxacin solution.Materials and methods. A multicenter randomized comparative clinical trial included adults with acute purulent otitis media or exacerbation of chronic purulent otitis media and during 6 face-to-face visits (days 1st, 3rd, 6th, 9th, as well as a therapy completion visit and a follow-up visit), the effect of drugs was evaluated according to examination, otoscopy, microbiological and audiometric examinations. Safety was assessed by the frequency of adverse events and the results of blood, urine tests and vital signs.Results. The achievement of the primary criteria was evaluated among 164 participants randomized into 2 groups: the proportion of patients with no indications for systemic antibacterial therapy at Visit 2 and with no ear pain at Visit 4, Dioxydin® ear drops had no less effectiveness than the comparison drug (64.6 and 89.9% versus 68.3 and 87.3%, respectively). In terms of the frequency of elimination of the pathogen and improvement of air conduction, the compared drugs also had no statistically significant differences, and according to some secondary criteria, Dioxydin® significantly exceeded 0.3% ciprofloxacin solution (the proportion of patients with a pronounced decrease in pain and congestion in the ear, as well as hyperemia of the eardrum). According to the safety criteria, the compared drugs had no significant differences.Conclusions. The results of the study confirmed the high efficacy and safety of Dioxydin® ear drops in the treatment of otitis media in adults.
- 8 April 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 52-63
Open AccessRecommendations for topical antimicrobial therapy of inflammatory diseases of the middle ear based on the results of evidence-based clinical study
Introduction. In conditions of widespread resistance of pathogens to traditional antimicrobial drugs, active attention is paid to the development of topical antimicrobial drugs for the effective treatment of inflammatory pathology of the middle ear.Aim. To study the efficacy and safety of a new dosage form of the drug Dioxydin® (2.5 mg/ml ear drops) in the treatment of patients with acute purulent otitis media and exacerbation of chronic purulent otitis media in comparison with ear drops containing 0.3% ciprofloxacin solution.Materials and methods. A multicenter randomized comparative clinical trial included adults with acute purulent otitis media or exacerbation of chronic purulent otitis media and during 6 face-to-face visits (days 1st, 3rd, 6th, 9th, as well as a therapy completion visit and a follow-up visit), the effect of drugs was evaluated according to examination, otoscopy, microbiological and audiometric examinations. Safety was assessed by the frequency of adverse events and the results of blood, urine tests and vital signs.Results. The achievement of the primary criteria was evaluated among 164 participants randomized into 2 groups: the proportion of patients with no indications for systemic antibacterial therapy at Visit 2 and with no ear pain at Visit 4, Dioxydin® ear drops had no less effectiveness than the comparison drug (64.6 and 89.9% versus 68.3 and 87.3%, respectively). In terms of the frequency of elimination of the pathogen and improvement of air conduction, the compared drugs also had no statistically significant differences, and according to some secondary criteria, Dioxydin® significantly exceeded 0.3% ciprofloxacin solution (the proportion of patients with a pronounced decrease in pain and congestion in the ear, as well as hyperemia of the eardrum). According to the safety criteria, the compared drugs had no significant differences.Conclusions. The results of the study confirmed the high efficacy and safety of Dioxydin® ear drops in the treatment of otitis media in adults.
- Open Access
- 30 December 2023
- Published by IRBIS in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
- Vol. 16 (4) , 587-595
Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis
Background. There are numerous diagnostic methods and therapy regimens for chronic tonsillitis (CT). Different methods of treatment in certain conditions do not always show high efficiency, so the search for new ways of conservative management of CT is needed, the main task of which is palatine tonsils preservation.Objective: to evaluate the efficacy and tolerability of a multicomponent preparation with low dosage of active substances Lymphomyosot® in adult patients with CT and cervical lymphadenopathy in real clinical practice.Material and methods. A total of 170 male and female patients aged 18–65 years with CT (simple form and 1st degree toxic-allergic form) and cervical lymphadenopathy were included in an observational, open, prospective study. In the main group (n=85), a combined therapy consisting of standard CT therapy (a course of palatine tonsils lavage with 0.9% NaCl solution) with the addition of Lymphomyosot® was administered. In the control group (n=85), topical non-steroidal anti-inflammatory drugs or phytotherapy were used instead of the studied drug. Ultrasound examination of regional cervical lymph nodes with measuring of their diameter (longitudinal, transverse) was chosen as a parameter of objective assessment of patients' condition dynamics. The results of therapy at Visit 1 and Visit 2 (12±2 days after Visit 1) were compared. The effectiveness of treatment regimens was analyzed according to the following parameters: complaints related to CT; oropharyngoscopic data; evaluation of CT indicators by the doctor and the patients; dynamics of cervical regional lymph nodes size; satisfaction of the doctor and the patients with the clinical effect and tolerability of therapy.Results. The dynamic observation showed a significant decrease in the number of complaints and symptoms according to objective examination, oropharyngoscopy, as well as evaluation of symptoms by the doctor and the patients at Visit 2 in both groups (pConclusion. The study demonstrated that Lymphomyosot® increased the efficacy of complex therapy, reducing cervical lymphoadenopathy and other manifestations of the disease in patients with CT (simple and 1st degree toxic-allergic forms).
- 30 December 2023
- Published by IRBIS in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
- Vol. 16 (4) , 587-595
Open AccessPossibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis
Background. There are numerous diagnostic methods and therapy regimens for chronic tonsillitis (CT). Different methods of treatment in certain conditions do not always show high efficiency, so the search for new ways of conservative management of CT is needed, the main task of which is palatine tonsils preservation.Objective: to evaluate the efficacy and tolerability of a multicomponent preparation with low dosage of active substances Lymphomyosot® in adult patients with CT and cervical lymphadenopathy in real clinical practice.Material and methods. A total of 170 male and female patients aged 18–65 years with CT (simple form and 1st degree toxic-allergic form) and cervical lymphadenopathy were included in an observational, open, prospective study. In the main group (n=85), a combined therapy consisting of standard CT therapy (a course of palatine tonsils lavage with 0.9% NaCl solution) with the addition of Lymphomyosot® was administered. In the control group (n=85), topical non-steroidal anti-inflammatory drugs or phytotherapy were used instead of the studied drug. Ultrasound examination of regional cervical lymph nodes with measuring of their diameter (longitudinal, transverse) was chosen as a parameter of objective assessment of patients' condition dynamics. The results of therapy at Visit 1 and Visit 2 (12±2 days after Visit 1) were compared. The effectiveness of treatment regimens was analyzed according to the following parameters: complaints related to CT; oropharyngoscopic data; evaluation of CT indicators by the doctor and the patients; dynamics of cervical regional lymph nodes size; satisfaction of the doctor and the patients with the clinical effect and tolerability of therapy.Results. The dynamic observation showed a significant decrease in the number of complaints and symptoms according to objective examination, oropharyngoscopy, as well as evaluation of symptoms by the doctor and the patients at Visit 2 in both groups (pConclusion. The study demonstrated that Lymphomyosot® increased the efficacy of complex therapy, reducing cervical lymphoadenopathy and other manifestations of the disease in patients with CT (simple and 1st degree toxic-allergic forms).
- 28 September 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 88 (4) , 93-102
New effects of a topical antimicrobial (agent) in the treatment of acute tonsillopharyngitis
Sore throat is the leading symptom of acute tonsillopharyngitis associated with previous acute respiratory viral infections, including COVID-19. The pathogenesis of these nosologies is based on the cumulative result of the primary direct damaging effect of viruses and secondary alternative inflammatory changes in the mucosal epithelium in the focus of infection, which, against the background of changes in the functions of the regional microbiota, leads to the development of viral-bacterial inflammation that goes beyond the protective-reparative level. In the treatment of acute tonsillopharyngitis after exclusion of GABHS etiology, topical etiotropic drugs are often used. It is desirable to achieve a uniform distribution of active ingredients, and to maximize the use of additional pharmacological capabilities (irrigation-eliminative action, reparative effect). To build up the evidence base for the effectiveness of just such medicines on the basis of the Department of Otorhinolaryngology of the Moscow State Medical University named after. A.I. Evdokimov, an observational prospective comparative study was conducted, using, in addition to the clinical assessment method, cytomorphological approaches (cytomorphometry). The results of the study demonstrated that gargling with a solution of hydroxymethylquinoxylindioxide (Dioxydin 0.25 mg/ml solution for topical application) in adult patients with acute tonsillopharyngitis provides rapid relief of pain, a decrease in the severity of inflammation symptoms, and also makes it possible to achieve limitation of the degree of destruction of the epithelium in the height of inflammation and a more complete and rapid recovery of the damaged mucous membrane by the time of recovery.
- 28 September 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 88 (4) , 93-102
New effects of a topical antimicrobial (agent) in the treatment of acute tonsillopharyngitis
Sore throat is the leading symptom of acute tonsillopharyngitis associated with previous acute respiratory viral infections, including COVID-19. The pathogenesis of these nosologies is based on the cumulative result of the primary direct damaging effect of viruses and secondary alternative inflammatory changes in the mucosal epithelium in the focus of infection, which, against the background of changes in the functions of the regional microbiota, leads to the development of viral-bacterial inflammation that goes beyond the protective-reparative level. In the treatment of acute tonsillopharyngitis after exclusion of GABHS etiology, topical etiotropic drugs are often used. It is desirable to achieve a uniform distribution of active ingredients, and to maximize the use of additional pharmacological capabilities (irrigation-eliminative action, reparative effect). To build up the evidence base for the effectiveness of just such medicines on the basis of the Department of Otorhinolaryngology of the Moscow State Medical University named after. A.I. Evdokimov, an observational prospective comparative study was conducted, using, in addition to the clinical assessment method, cytomorphological approaches (cytomorphometry). The results of the study demonstrated that gargling with a solution of hydroxymethylquinoxylindioxide (Dioxydin 0.25 mg/ml solution for topical application) in adult patients with acute tonsillopharyngitis provides rapid relief of pain, a decrease in the severity of inflammation symptoms, and also makes it possible to achieve limitation of the degree of destruction of the epithelium in the height of inflammation and a more complete and rapid recovery of the damaged mucous membrane by the time of recovery.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 87 (3) , 30-39
Modern H1 antihistamines in the treatment of patients with allergic rhinitis and comorbid acute respiratory infections
Пациенты с аллергическим ринитом (АР) имеют предрасположенность к частым острым респираторным вирусным инфекциям (ОРВИ). Воспаление слизистой оболочки полости носа и околоносовых пазух у таких больных более выраженное на фоне сочетания аллергического и инфекционного воспаления. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить влияние терапии с применением современных антигистаминных препаратов на состояние и выраженность симптомов у взрослых пациентов с обострением АР, вызванного пыльцой растений (САР), и развитием ОРВИ. МАТЕРИАЛ И МЕТОДЫ На кафедре оториноларингологии ФГБОУ ВО «МГМСУ им. А.И. Евдокимова» Минздрава России с апреля по август 2021 г. проведено наблюдательное исследование. Включены пациенты обоих полов в возрасте от 18 до 65 лет с ранее (не менее 1 года назад) верифицированным диагнозом САР легкой и средней степени тяжести в стадии обострения, обратившиеся за медицинской помощью по поводу ОРВИ. Всем больным назначали терапию с включением препарата, относящегося к фармакологической группе антигистаминных препаратов 2-го поколения (АГП-2п) (курсом 14 дней). Кроме того, больные получали по показаниям симптоматическую терапию ОРВИ, включая назальные деконгестанты (по потребности), жаропонижающие и противокашлевые препараты. РЕЗУЛЬТАТЫ На основании полученных данных удалось доказать, что применение современных антигистаминных препаратов у пациентов, коморбидных в отношении АР и ОРВИ, оказывает выраженное лечебное действие. Теоритин обеспечивает терапевтический эффект в ранние сроки в отношении назальных и неназальных симптомов сезонного обострения АР/ОРВИ, а также быстро улучшает качество жизни пациентов, что делает перспективным его применение для лечения ОРВИ на фоне АР. Препарат имеет сопоставимую с цетиризином противогистаминную активность и превосходит его по способности подавлять аллергическую воспалительную реакцию, например на коже, а также по длительности сохранения антигистаминного эффекта. ЗАКЛЮЧЕНИЕ Представленные результаты свидетельствуют об эффективности теоритина и цетиризина в лечении пациентов с сезонным обострением аллергического ринита, коморбидных по острым респираторным вирусным инфекциям.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 87 (3) , 30-39
Modern H1 antihistamines in the treatment of patients with allergic rhinitis and comorbid acute respiratory infections
Пациенты с аллергическим ринитом (АР) имеют предрасположенность к частым острым респираторным вирусным инфекциям (ОРВИ). Воспаление слизистой оболочки полости носа и околоносовых пазух у таких больных более выраженное на фоне сочетания аллергического и инфекционного воспаления. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить влияние терапии с применением современных антигистаминных препаратов на состояние и выраженность симптомов у взрослых пациентов с обострением АР, вызванного пыльцой растений (САР), и развитием ОРВИ. МАТЕРИАЛ И МЕТОДЫ На кафедре оториноларингологии ФГБОУ ВО «МГМСУ им. А.И. Евдокимова» Минздрава России с апреля по август 2021 г. проведено наблюдательное исследование. Включены пациенты обоих полов в возрасте от 18 до 65 лет с ранее (не менее 1 года назад) верифицированным диагнозом САР легкой и средней степени тяжести в стадии обострения, обратившиеся за медицинской помощью по поводу ОРВИ. Всем больным назначали терапию с включением препарата, относящегося к фармакологической группе антигистаминных препаратов 2-го поколения (АГП-2п) (курсом 14 дней). Кроме того, больные получали по показаниям симптоматическую терапию ОРВИ, включая назальные деконгестанты (по потребности), жаропонижающие и противокашлевые препараты. РЕЗУЛЬТАТЫ На основании полученных данных удалось доказать, что применение современных антигистаминных препаратов у пациентов, коморбидных в отношении АР и ОРВИ, оказывает выраженное лечебное действие. Теоритин обеспечивает терапевтический эффект в ранние сроки в отношении назальных и неназальных симптомов сезонного обострения АР/ОРВИ, а также быстро улучшает качество жизни пациентов, что делает перспективным его применение для лечения ОРВИ на фоне АР. Препарат имеет сопоставимую с цетиризином противогистаминную активность и превосходит его по способности подавлять аллергическую воспалительную реакцию, например на коже, а также по длительности сохранения антигистаминного эффекта. ЗАКЛЮЧЕНИЕ Представленные результаты свидетельствуют об эффективности теоритина и цетиризина в лечении пациентов с сезонным обострением аллергического ринита, коморбидных по острым респираторным вирусным инфекциям.
- Open Access
- 1 December 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 18,p. 62-67
From clinical guidelines to practice. Clinical experience in treatment of patients with allergic rhinitis
Introduction. Antihistamines are the most commonly prescribed class of medications for the treatment of allergic rhinitis (AR). However, they are also widely used in the treatment of inflammatory diseases of the ENT organs. One such drug is levocytirizine, (R) an enantiomer of cetirizine, which is a selective antagonist of peripheral histamine H1-receptors. This article analyzes the properties of levocytirizine in terms of safety and efficacy in allergic rhinitis.Aim of the study is to assess the efficacy of levocetirizine in patients with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) versus placebo, and safety for patients with allergic rhinitis.Materials and methods. In this, double-blind, placebo-controlled study, 52 patients with year-round allergic rhinitis and 28 patients with seasonal allergic rhinitis were randomized to receive levocetirizine 5 mg/day once or placebo. Mean overall measures of five symptoms (nasal congestion, nasal itching, itchy eyes, rhinorrhea, and sneezing) were compared between treatment groups at 1, 2, and 4 weeks. All individual symptom scores were also examined.Results. Levocetirizine showed a significant improvement in the condition of patients with CAR and SAR over the entire treatment period compared to placebo. Assessment of individual symptoms showed statistically significant differences in favor of levocetirizine. Conclusion. Levocetirizine is an effective, safe, and well-tolerated drug for the treatment of allergic rhinitis.
- 1 December 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 18,p. 62-67
Open AccessFrom clinical guidelines to practice. Clinical experience in treatment of patients with allergic rhinitis
Introduction. Antihistamines are the most commonly prescribed class of medications for the treatment of allergic rhinitis (AR). However, they are also widely used in the treatment of inflammatory diseases of the ENT organs. One such drug is levocytirizine, (R) an enantiomer of cetirizine, which is a selective antagonist of peripheral histamine H1-receptors. This article analyzes the properties of levocytirizine in terms of safety and efficacy in allergic rhinitis.Aim of the study is to assess the efficacy of levocetirizine in patients with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) versus placebo, and safety for patients with allergic rhinitis.Materials and methods. In this, double-blind, placebo-controlled study, 52 patients with year-round allergic rhinitis and 28 patients with seasonal allergic rhinitis were randomized to receive levocetirizine 5 mg/day once or placebo. Mean overall measures of five symptoms (nasal congestion, nasal itching, itchy eyes, rhinorrhea, and sneezing) were compared between treatment groups at 1, 2, and 4 weeks. All individual symptom scores were also examined.Results. Levocetirizine showed a significant improvement in the condition of patients with CAR and SAR over the entire treatment period compared to placebo. Assessment of individual symptoms showed statistically significant differences in favor of levocetirizine. Conclusion. Levocetirizine is an effective, safe, and well-tolerated drug for the treatment of allergic rhinitis.
- Open Access
- 12 May 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 21-27
Rational topical treatment of uncomplicated rhinosinusitis as a basis for successful recovery
The article is devoted to the treatment of one of the most common diseases - the treatment of rhinosinusitis. According to statistics only 2% of the sinusitis in population are bacterial. At the same time administration of systemic antibiotic therapy reaches 95.5%. The problem of rational prescription of antibacterial drugs, including management of the rhinosinusitis, is very acute, especially considering the constant increase in the number of antibiotic-resistant microorganisms. Currently, the level of patients with prolonged post-viral rhinosinusitis after COVID-19 has increased. Most have a history of one or more courses of systemic antibiotics and, often, without indications. In article are listed indications for systemic and local antibacterial therapy in adults and children, based on national and European clinical guidelines. The data on complications during the use of systemic antibacterial drugs are presented. Authors give information about the advantages of the local use of antibiotics: the absence of general toxic complications, the creation of an optimal concentration directly in the focus of inflammation. The advantages of combining solutions of neomycin and polymyxin B for topical use, such as a pronounced bactericidal effect against gram-positive and gram-negative bacteria (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa), causing the development of infectious processes in the upper respiratory tract, are separately noted. The author describes his own experience of using the original nasal spray Polydex with phenylephrine, containing a fixed combination of neomycin, polymyxin B, dexamethasone sodium metasulfobenzoate and phenylephrine, in the treatment of patients with post-viral rhinosinusitis. As a result of the collection of literature data, as well as based on their own experience, the authors concluded that the use of this nasal spray in outpatient practice will significantly improve the effectiveness of treatment and reduce the frequency of prescribing systemic antibiotics.
- 12 May 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 21-27
Open AccessRational topical treatment of uncomplicated rhinosinusitis as a basis for successful recovery
The article is devoted to the treatment of one of the most common diseases - the treatment of rhinosinusitis. According to statistics only 2% of the sinusitis in population are bacterial. At the same time administration of systemic antibiotic therapy reaches 95.5%. The problem of rational prescription of antibacterial drugs, including management of the rhinosinusitis, is very acute, especially considering the constant increase in the number of antibiotic-resistant microorganisms. Currently, the level of patients with prolonged post-viral rhinosinusitis after COVID-19 has increased. Most have a history of one or more courses of systemic antibiotics and, often, without indications. In article are listed indications for systemic and local antibacterial therapy in adults and children, based on national and European clinical guidelines. The data on complications during the use of systemic antibacterial drugs are presented. Authors give information about the advantages of the local use of antibiotics: the absence of general toxic complications, the creation of an optimal concentration directly in the focus of inflammation. The advantages of combining solutions of neomycin and polymyxin B for topical use, such as a pronounced bactericidal effect against gram-positive and gram-negative bacteria (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa), causing the development of infectious processes in the upper respiratory tract, are separately noted. The author describes his own experience of using the original nasal spray Polydex with phenylephrine, containing a fixed combination of neomycin, polymyxin B, dexamethasone sodium metasulfobenzoate and phenylephrine, in the treatment of patients with post-viral rhinosinusitis. As a result of the collection of literature data, as well as based on their own experience, the authors concluded that the use of this nasal spray in outpatient practice will significantly improve the effectiveness of treatment and reduce the frequency of prescribing systemic antibiotics.